HWAM
VERA icon

Hennion & Walsh Asset Management’s Vera Therapeutics VERA Stock Holding History

Hennion & Walsh Asset Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Sell
42,506
-372
-0.9% -$13.9K 0.05% 406
2026
Q1 		$1.72M Buy
42,878
+504
+1% +$21.7K 0.06% 387
2025
Q4 		$2.15M Buy
42,374
+10,088
+31% +$358K 0.07% 339
2025
Q3 		$938K Buy
32,286
+13,289
+70% +$307K 0.03% 524
2025
Q2 		$448K Buy
+18,997
New +$427K 0.02% 706

Other funds holding VERA

EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

Hennion & Walsh Asset Management's VERA Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Vera Therapeutics (VERA) stake by 0.87% in Q2 2026, selling an estimated $13.9K and leaving 42,506 shares worth $1.82M. The position accounts for 0.05% of the portfolio, ranked #406.

Hennion & Walsh Asset Management first reported a position in VERA in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.15M in Q4 2025. 11 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Hennion & Walsh Asset Management held 42,506 shares of Vera Therapeutics worth $1.82M as of Q2 2026.
  • Hennion & Walsh Asset Management sold 372 Vera Therapeutics shares in Q2 2026, an estimated $13.9K.
  • Vera Therapeutics made up 0.05% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #406 holding.
  • Hennion & Walsh Asset Management first reported a position in Vera Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Hennion & Walsh Asset Management's Vera Therapeutics position peaked at $2.15M in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.